002286 Stock Overview
Researches and develops, manufactures, and sells a range of functional sugars in China. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Baolingbao Biology Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥7.56 |
52 Week High | CN¥8.55 |
52 Week Low | CN¥4.63 |
Beta | 0.71 |
1 Month Change | 4.56% |
3 Month Change | 17.21% |
1 Year Change | -5.74% |
3 Year Change | -42.60% |
5 Year Change | 25.58% |
Change since IPO | -15.14% |
Recent News & Updates
A Look At The Intrinsic Value Of Baolingbao Biology Co.,Ltd. (SZSE:002286)
Nov 29Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues
Nov 05Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up
Oct 08Recent updates
A Look At The Intrinsic Value Of Baolingbao Biology Co.,Ltd. (SZSE:002286)
Nov 29Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues
Nov 05Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up
Oct 08We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)
Sep 30Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price
Jul 03Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled
Jun 07Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders
May 06Shareholder Returns
002286 | CN Food | CN Market | |
---|---|---|---|
7D | -6.0% | -1.1% | 0.4% |
1Y | -5.7% | 4.2% | 12.3% |
Return vs Industry: 002286 underperformed the CN Food industry which returned 4.2% over the past year.
Return vs Market: 002286 underperformed the CN Market which returned 12.3% over the past year.
Price Volatility
002286 volatility | |
---|---|
002286 Average Weekly Movement | 6.5% |
Food Industry Average Movement | 7.5% |
Market Average Movement | 8.8% |
10% most volatile stocks in CN Market | 13.0% |
10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 002286 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002286's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 1,216 | Sijue Dai | www.blb-cn.com |
Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, including oligomaltose, fructose syrup, solid corn syrup, maltodextrin, and glucose syrup; and animal nutrition products comprising baolekang and fubaokang.
Baolingbao Biology Co.,Ltd. Fundamentals Summary
002286 fundamental statistics | |
---|---|
Market cap | CN¥2.87b |
Earnings (TTM) | CN¥109.05m |
Revenue (TTM) | CN¥2.39b |
25.6x
P/E Ratio1.2x
P/S RatioIs 002286 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002286 income statement (TTM) | |
---|---|
Revenue | CN¥2.39b |
Cost of Revenue | CN¥2.16b |
Gross Profit | CN¥229.35m |
Other Expenses | CN¥120.30m |
Earnings | CN¥109.05m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.29 |
Gross Margin | 9.59% |
Net Profit Margin | 4.56% |
Debt/Equity Ratio | 17.9% |
How did 002286 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield37%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 16:42 |
End of Day Share Price | 2024/12/25 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Baolingbao Biology Co.,Ltd. is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yalei Yan | Bohai Securities Co., Ltd. |
YANG QIAO | Changjiang Securities Co. LTD. |
Jiawei Liu | Dongxing Securities Company Limited |